Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue JCI Insight Année : 2020

Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation

Norbert Minet
  • Fonction : Auteur
  • PersonId : 951967
Steicy Sobrino
  • Fonction : Auteur
Capucine Picard
Tim Bourne
  • Fonction : Auteur
Sophie Hambleton
  • Fonction : Auteur
  • PersonId : 1062331
Tracy Briggs
  • Fonction : Auteur
  • PersonId : 1062332
Monica Lawrence
  • Fonction : Auteur

Résumé

Cytidine triphosphate (CTP) synthetase 1 (CTPS1) deficiency is caused by a unique homozygous frameshift splice mutation (c.1692-1G>C, p.T566Dfs26X). CTPS1-deficient patients display severe bacterial and viral infections. CTPS1 is responsible for CTP nucleotide de novo production involved in DNA/RNA synthesis. Herein, we characterized in depth lymphocyte defects associated with CTPS1 deficiency. Immune phenotyping performed in 7 patients showed absence or low numbers of mucosal-associated T cells, invariant NKT cells, memory B cells, and NK cells, whereas other subsets were normal. Proliferation and IL-2 secretion by T cells in response to TCR activation were markedly decreased in all patients, while other T cell effector functions were preserved. The CTPS1 T566Dfs26X mutant protein was found to be hypomorphic, resulting in 80%-90% reduction of protein expression and CTPS activity in cells of patients. Inactivation of CTPS1 in a T cell leukemia fully abolished cell proliferation. Expression of CTPS1 T566Dfs26X failed to restore proliferation of CTPS1-deficient leukemia cells to normal, except when forcing its expression to a level comparable to that of WT CTPS1. This indicates that CTPS1 T566Dfs26X retained normal CTPS activity, and thus the loss of function of CTPS1 T566Dfs26X is completely attributable to protein instability. This study supports that CTPS1 represents an attractive therapeutic target to selectively inhibit pathological T cell proliferation, including lymphoma.
Fichier principal
Vignette du fichier
133880.2-20200313095702-covered-253bed37ca4c1ab43d105aefdf7b5536.pdf (1.97 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02937426 , version 1 (05-11-2020)

Identifiants

Citer

Emmanuel Martin, Norbert Minet, Anne-Claire Boschat, Sylvia Sanquer, Steicy Sobrino, et al.. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight, 2020, 5 (5), ⟨10.1172/jci.insight.133880⟩. ⟨hal-02937426⟩
81 Consultations
34 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More